Concepedia

Patrick Costello

PC

Statistics

Publications

14

Citations

580

H-Index

12

Active since

1985

Affiliations

Dana-Farber Cancer Institute(Current)

The University of Texas MD Anderson Cancer Center

Levine Cancer Institute

Cleveland Clinic

Moffitt Cancer Center

Patrick Costello is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and multiple myeloma treatment.

ORCID

Publications per year

1985–2025

14

Publications

14

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 124 citations · Full text

, , +14

Prognostic significance of microvessel density in lymph node negative breast carcinoma

Patrick Costello, Amanda McCann, Desmond N. Carney et al. · Human Pathology · 1995 · 121 citations

, , +12

Frequent loss of imprinting of PEG1/MEST in invasive breast cancer.

Inge Søkilde Pedersen, P. Dervan, Daniel F. Broderick et al. · PubMed · 1999 · 94 citations

, , +15

EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma

Jan Frenking, Xiang Zhou, Thomas Hielscher et al. · Journal for ImmunoTherapy of Cancer · 2024 · 40 citations · Full text

, , +17

Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM).

Doris K. Hansen, Krina K. Patel, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 36 citations

, , +14

1–5 of 14